Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-05-22

FDA Approved: CLINDAMYCIN PHOSPHATE — Supplemental Application (i3 Pharmaceuticals, LLC)

View source ↗

Summary

FDA approved a supplemental application for Clindamycin Phosphate Topical from i3 Pharmaceuticals, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Clindamycin phosphate topical (Clindamycin phosphate topical)

Snippet

SUPPL AP for CLINDAMYCIN PHOSPHATE (CLINDAMYCIN PHOSPHATE TOPICAL)